» Articles » PMID: 27354240

Thermal Unfolding Simulations of NBD1 Domain Variants Reveal Structural Motifs Associated with the Impaired Folding of F508del-CFTR

Overview
Journal Mol Biosyst
Date 2016 Jun 30
PMID 27354240
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

We employed high-temperature classical molecular dynamics (MD) simulations to investigate the unfolding process of the wild-type (WT) and F508del-NBD1 domains of CFTR protein, with and without second-site mutations. To rationalize the in vitro behavior of F508del-NBD1, namely its lower folding yield and higher aggregation propensity, we focused our analysis of the MD data on the existence of intermediate states with aggregation potential and/or stabilized by a significant number of non-native interactions (i.e. misfolded states). We find that the deletion of phenylalanine 508 is able to forcefully reshape the conformational space of the NBD1 domain to the extent that it uniquely populates intermediate states whose structural traits provide important insights into the molecular events that underlie the impaired folding of F508del-NBD1. In particular, our simulations predict the formation of a misfolded intermediate whose population is highly enhanced by deletion of residue 508. The stabilization of this intermediate is a direct consequence of the enhanced non-native coupling between various key regions of the α-helical subdomain and ATP-binding subdomain; it is singularly characterized by a set of non-native interactions within the ATP-binding subdomain and between that domain and the α-helical subdomain region. The formation of this intermediate is not blocked by second-site suppressor mutations which indicates a limited role of the latter in correcting the rather complex folding process of the CFTR protein missing residue 508.

Citing Articles

Structural Comparative Modeling of Multi-Domain F508del CFTR.

McDonald E, Woods H, Smith S, Kim M, Schoeder C, Plate L Biomolecules. 2022; 12(3).

PMID: 35327663 PMC: 8946492. DOI: 10.3390/biom12030471.


A small molecule high throughput screening platform to profile conformational properties of nascent, ribosome-bound proteins.

Shishido H, Yoon J, Skach W Sci Rep. 2022; 12(1):2509.

PMID: 35169219 PMC: 8847357. DOI: 10.1038/s41598-022-06456-5.


CFTR trafficking mutations disrupt cotranslational protein folding by targeting biosynthetic intermediates.

Shishido H, Yoon J, Yang Z, Skach W Nat Commun. 2020; 11(1):4258.

PMID: 32848127 PMC: 7450043. DOI: 10.1038/s41467-020-18101-8.


A Proteomic Variant Approach (ProVarA) for Personalized Medicine of Inherited and Somatic Disease.

Hutt D, Loguercio S, Campos A, Balch W J Mol Biol. 2018; 430(18 Pt A):2951-2973.

PMID: 29924966 PMC: 6097907. DOI: 10.1016/j.jmb.2018.06.017.


Structural stability of purified human CFTR is systematically improved by mutations in nucleotide binding domain 1.

Yang Z, Hildebrandt E, Jiang F, Aleksandrov A, Khazanov N, Zhou Q Biochim Biophys Acta Biomembr. 2018; 1860(5):1193-1204.

PMID: 29425673 PMC: 6319260. DOI: 10.1016/j.bbamem.2018.02.006.